

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 4.30084186 |
| 2 | aggressive behavior (GO:0002118) | 4.19869977 |
| 3 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.12746093 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.86736576 |
| 5 | negative regulation of cell killing (GO:0031342) | 3.86736576 |
| 6 | adenosine receptor signaling pathway (GO:0001973) | 3.85856936 |
| 7 | regulation of penile erection (GO:0060405) | 3.76010381 |
| 8 | GDP-mannose metabolic process (GO:0019673) | 3.70609386 |
| 9 | positive thymic T cell selection (GO:0045059) | 3.58164434 |
| 10 | female mating behavior (GO:0060180) | 3.56834358 |
| 11 | cellular response to virus (GO:0098586) | 3.56197377 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55568668 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.53840807 |
| 14 | mature B cell differentiation involved in immune response (GO:0002313) | 3.53183684 |
| 15 | seminiferous tubule development (GO:0072520) | 3.46727513 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30994507 |
| 17 | regulation of female receptivity (GO:0045924) | 3.30895853 |
| 18 | peroxisome fission (GO:0016559) | 3.28806207 |
| 19 | amino sugar catabolic process (GO:0046348) | 3.26837727 |
| 20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23850159 |
| 21 | protein kinase C signaling (GO:0070528) | 3.22395608 |
| 22 | UV protection (GO:0009650) | 3.16983498 |
| 23 | negative T cell selection (GO:0043383) | 3.15433131 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11265753 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.08278047 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07627943 |
| 27 | cellular response to interferon-beta (GO:0035458) | 3.06188286 |
| 28 | grooming behavior (GO:0007625) | 3.06086308 |
| 29 | cellular response to exogenous dsRNA (GO:0071360) | 3.04258220 |
| 30 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.01518764 |
| 31 | thymic T cell selection (GO:0045061) | 2.95430035 |
| 32 | actin nucleation (GO:0045010) | 2.91714207 |
| 33 | mature B cell differentiation (GO:0002335) | 2.88573572 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86855487 |
| 35 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.86422584 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 2.86255011 |
| 37 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.86237412 |
| 38 | purine nucleotide salvage (GO:0032261) | 2.82685959 |
| 39 | positive T cell selection (GO:0043368) | 2.82316039 |
| 40 | megakaryocyte development (GO:0035855) | 2.80910371 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 2.80790740 |
| 42 | maternal behavior (GO:0042711) | 2.79928531 |
| 43 | T cell migration (GO:0072678) | 2.78845739 |
| 44 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.76927400 |
| 45 | iron-sulfur cluster assembly (GO:0016226) | 2.76507592 |
| 46 | metallo-sulfur cluster assembly (GO:0031163) | 2.76507592 |
| 47 | N-acetylneuraminate metabolic process (GO:0006054) | 2.75985946 |
| 48 | purinergic receptor signaling pathway (GO:0035587) | 2.75573195 |
| 49 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.75458127 |
| 50 | response to muramyl dipeptide (GO:0032495) | 2.72407638 |
| 51 | establishment of mitochondrion localization (GO:0051654) | 2.71442731 |
| 52 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.70202528 |
| 53 | mitochondrion transport along microtubule (GO:0047497) | 2.70202528 |
| 54 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.69003059 |
| 55 | positive regulation of defense response to virus by host (GO:0002230) | 2.68492941 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68264394 |
| 57 | mast cell activation (GO:0045576) | 2.67528648 |
| 58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66702865 |
| 59 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.65249959 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.65080395 |
| 61 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.64277001 |
| 62 | inositol phosphate dephosphorylation (GO:0046855) | 2.64277001 |
| 63 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.64214011 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.63844858 |
| 65 | T cell selection (GO:0045058) | 2.62399113 |
| 66 | positive regulation of odontogenesis (GO:0042482) | 2.62021455 |
| 67 | deoxyribonucleotide catabolic process (GO:0009264) | 2.59116289 |
| 68 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.58606580 |
| 69 | regulation of B cell differentiation (GO:0045577) | 2.54220832 |
| 70 | protein insertion into membrane (GO:0051205) | 2.53657497 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.53380690 |
| 72 | negative regulation of interleukin-2 production (GO:0032703) | 2.53145771 |
| 73 | cellular response to interleukin-15 (GO:0071350) | 2.52252810 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 2.51121651 |
| 75 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.50758637 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 2.50744669 |
| 77 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.50274968 |
| 78 | modulation by virus of host process (GO:0019054) | 2.50179902 |
| 79 | mast cell degranulation (GO:0043303) | 2.49785426 |
| 80 | mast cell activation involved in immune response (GO:0002279) | 2.49785426 |
| 81 | tolerance induction (GO:0002507) | 2.48308803 |
| 82 | positive regulation of isotype switching (GO:0045830) | 2.48100375 |
| 83 | regulation of skeletal muscle contraction (GO:0014819) | 2.47239766 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46865674 |
| 85 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45455844 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.42465409 |
| 87 | negative regulation of B cell apoptotic process (GO:0002903) | 2.41883673 |
| 88 | regulated secretory pathway (GO:0045055) | 2.41802698 |
| 89 | leukocyte degranulation (GO:0043299) | 2.41378517 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 2.40632157 |
| 91 | barbed-end actin filament capping (GO:0051016) | 2.39674435 |
| 92 | inositol phosphate catabolic process (GO:0071545) | 2.38809712 |
| 93 | response to peptidoglycan (GO:0032494) | 2.37388353 |
| 94 | deoxyribose phosphate catabolic process (GO:0046386) | 2.36934667 |
| 95 | positive regulation of macrophage differentiation (GO:0045651) | 2.36325414 |
| 96 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.36241737 |
| 97 | negative regulation of innate immune response (GO:0045824) | 2.36049608 |
| 98 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.35898084 |
| 99 | response to interferon-beta (GO:0035456) | 2.35575083 |
| 100 | Peyers patch development (GO:0048541) | 2.33676749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.59323283 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.43302219 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.53720984 |
| 4 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.46371678 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.46353597 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43263212 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41454294 |
| 8 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34223823 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33070579 |
| 10 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.29674729 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.27742172 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22677885 |
| 13 | MAF_26560356_Chip-Seq_TH2_Human | 2.20816238 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18070209 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.13218255 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.12877125 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11721262 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05050958 |
| 19 | P68_20966046_ChIP-Seq_HELA_Human | 2.02765634 |
| 20 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00328042 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98465263 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97763188 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 1.95768031 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92589895 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.92070276 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.88795899 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.88510030 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.87215019 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86051533 |
| 30 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81149882 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79799008 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79614906 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73842443 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72459778 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69526071 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68303135 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67337670 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66393027 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.64492180 |
| 40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.64354046 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60900328 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59733881 |
| 43 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58123494 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56000619 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53236804 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52306653 |
| 47 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.51730259 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51081681 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50392378 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49932231 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48692699 |
| 52 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.47730337 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46665754 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44442554 |
| 55 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43632666 |
| 56 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.43500829 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42989495 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41981104 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41197665 |
| 60 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.40167414 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37668750 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31823260 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.31585815 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30783195 |
| 65 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.29894702 |
| 66 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29759658 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29110398 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28647760 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28583053 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28176725 |
| 71 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.25832649 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25191573 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24618051 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24519926 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19994280 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18045427 |
| 77 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17751048 |
| 78 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16820801 |
| 79 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16230972 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15769491 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14686442 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.14653182 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14608205 |
| 84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14362271 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14213404 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14120328 |
| 87 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.12576858 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11593562 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11071518 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10930186 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10720048 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10567623 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10538651 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10455007 |
| 95 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09167638 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09065358 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08696531 |
| 98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08517334 |
| 99 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08422165 |
| 100 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08172627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 3.45043731 |
| 2 | MP0001986_abnormal_taste_sensitivity | 2.67914184 |
| 3 | MP0009278_abnormal_bone_marrow | 2.59060210 |
| 4 | MP0003303_peritoneal_inflammation | 2.53390813 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.49419549 |
| 6 | MP0005423_abnormal_somatic_nervous | 2.38192164 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.19650770 |
| 8 | MP0003436_decreased_susceptibility_to | 2.15471981 |
| 9 | MP0005025_abnormal_response_to | 2.13963407 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.10516203 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.07735820 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.02730778 |
| 13 | MP0003183_abnormal_peptide_metabolism | 1.97726370 |
| 14 | MP0001800_abnormal_humoral_immune | 1.86036489 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 1.85438597 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 1.84676622 |
| 17 | MP0002723_abnormal_immune_serum | 1.84190393 |
| 18 | MP0008260_abnormal_autophagy | 1.83800861 |
| 19 | MP0005451_abnormal_body_composition | 1.78809791 |
| 20 | MP0000013_abnormal_adipose_tissue | 1.78399856 |
| 21 | MP0003724_increased_susceptibility_to | 1.77571304 |
| 22 | MP0005671_abnormal_response_to | 1.76256621 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.72921156 |
| 24 | MP0001819_abnormal_immune_cell | 1.70868887 |
| 25 | MP0000685_abnormal_immune_system | 1.70615592 |
| 26 | MP0002419_abnormal_innate_immunity | 1.67624984 |
| 27 | MP0005360_urolithiasis | 1.66925135 |
| 28 | MP0003786_premature_aging | 1.66030868 |
| 29 | MP0009785_altered_susceptibility_to | 1.63082138 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.63057877 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.62211938 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.61387038 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.60180479 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.60180479 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.59220622 |
| 36 | MP0002398_abnormal_bone_marrow | 1.58764980 |
| 37 | MP0004043_abnormal_pH_regulation | 1.55358036 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.50437781 |
| 39 | MP0002405_respiratory_system_inflammati | 1.50319433 |
| 40 | MP0001790_abnormal_immune_system | 1.49997362 |
| 41 | MP0005387_immune_system_phenotype | 1.49997362 |
| 42 | MP0001188_hyperpigmentation | 1.46361350 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.44643636 |
| 44 | MP0000716_abnormal_immune_system | 1.41159199 |
| 45 | MP0005083_abnormal_biliary_tract | 1.39716517 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.35755728 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.31083156 |
| 48 | MP0006054_spinal_hemorrhage | 1.30881223 |
| 49 | MP0001873_stomach_inflammation | 1.30309464 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.29997562 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.29332669 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.28181950 |
| 53 | MP0009840_abnormal_foam_cell | 1.27931642 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.27505184 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.26629739 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.26283575 |
| 57 | MP0002722_abnormal_immune_system | 1.25311530 |
| 58 | MP0001542_abnormal_bone_strength | 1.24379085 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.23674911 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.23192108 |
| 61 | MP0000751_myopathy | 1.22514993 |
| 62 | MP0002429_abnormal_blood_cell | 1.22229770 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.20638212 |
| 64 | MP0001663_abnormal_digestive_system | 1.20529814 |
| 65 | MP0008469_abnormal_protein_level | 1.19001310 |
| 66 | MP0003866_abnormal_defecation | 1.18132868 |
| 67 | MP0004947_skin_inflammation | 1.15421861 |
| 68 | MP0004130_abnormal_muscle_cell | 1.14632765 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.11021443 |
| 70 | MP0008789_abnormal_olfactory_epithelium | 1.10624371 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.10342373 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.09691573 |
| 73 | MP0000343_altered_response_to | 1.06703741 |
| 74 | MP0006082_CNS_inflammation | 1.06671401 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05686554 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.04367562 |
| 77 | MP0004147_increased_porphyrin_level | 1.03550258 |
| 78 | MP0001664_abnormal_digestion | 1.03535942 |
| 79 | MP0001905_abnormal_dopamine_level | 1.00432596 |
| 80 | MP0001533_abnormal_skeleton_physiology | 0.99742472 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.98938730 |
| 82 | MP0000358_abnormal_cell_content/ | 0.97956778 |
| 83 | MP0005171_absent_coat_pigmentation | 0.97908521 |
| 84 | MP0005310_abnormal_salivary_gland | 0.97810360 |
| 85 | MP0003279_aneurysm | 0.96304184 |
| 86 | MP0001756_abnormal_urination | 0.95464477 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.94041561 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.93830905 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.91910147 |
| 90 | MP0005499_abnormal_olfactory_system | 0.91910147 |
| 91 | MP0000604_amyloidosis | 0.89262818 |
| 92 | MP0003075_altered_response_to | 0.88578675 |
| 93 | MP0009764_decreased_sensitivity_to | 0.87544511 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.86631035 |
| 95 | MP0008004_abnormal_stomach_pH | 0.86355734 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.85887871 |
| 97 | MP0008569_lethality_at_weaning | 0.85761824 |
| 98 | MP0004142_abnormal_muscle_tone | 0.84900289 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82414433 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.81880669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 3.59933026 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 3.51163068 |
| 3 | Obstructive lung disease (HP:0006536) | 3.51163068 |
| 4 | Agammaglobulinemia (HP:0004432) | 3.47157729 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.20699738 |
| 6 | Increased IgE level (HP:0003212) | 3.18163929 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.17976049 |
| 8 | Poikiloderma (HP:0001029) | 3.13726808 |
| 9 | Mesangial abnormality (HP:0001966) | 3.13349754 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.09055750 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.09055750 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.05455585 |
| 13 | Hypertensive crisis (HP:0100735) | 3.00158306 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 2.93053309 |
| 15 | B lymphocytopenia (HP:0010976) | 2.92645175 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 2.88620625 |
| 17 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.79541252 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.74059438 |
| 19 | Petechiae (HP:0000967) | 2.73278647 |
| 20 | Ragged-red muscle fibers (HP:0003200) | 2.71884328 |
| 21 | Choroideremia (HP:0001139) | 2.70628680 |
| 22 | Eczematoid dermatitis (HP:0000976) | 2.69474679 |
| 23 | Microvesicular hepatic steatosis (HP:0001414) | 2.64258398 |
| 24 | Abnormality of B cell number (HP:0010975) | 2.62465489 |
| 25 | Annular pancreas (HP:0001734) | 2.61692244 |
| 26 | Increased muscle lipid content (HP:0009058) | 2.61472335 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.60944772 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.60533448 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 2.56452709 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56375140 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 2.54608222 |
| 32 | Recurrent viral infections (HP:0004429) | 2.53998446 |
| 33 | Flat capital femoral epiphysis (HP:0003370) | 2.49322870 |
| 34 | Epistaxis (HP:0000421) | 2.49114177 |
| 35 | Testicular atrophy (HP:0000029) | 2.48071050 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.45845756 |
| 37 | Severe combined immunodeficiency (HP:0004430) | 2.43671248 |
| 38 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.42259054 |
| 39 | Meningitis (HP:0001287) | 2.40335504 |
| 40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40301395 |
| 41 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36611398 |
| 42 | Dyschromatopsia (HP:0007641) | 2.36504735 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.35995584 |
| 44 | Acute hepatic failure (HP:0006554) | 2.33403086 |
| 45 | Colitis (HP:0002583) | 2.31887908 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.28859537 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27439086 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27439086 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27439086 |
| 50 | Thoracic kyphosis (HP:0002942) | 2.24736409 |
| 51 | Ileus (HP:0002595) | 2.24265370 |
| 52 | Renal Fanconi syndrome (HP:0001994) | 2.24139151 |
| 53 | Recurrent skin infections (HP:0001581) | 2.19446839 |
| 54 | Joint stiffness (HP:0001387) | 2.19389810 |
| 55 | Facial diplegia (HP:0001349) | 2.17038723 |
| 56 | Myositis (HP:0100614) | 2.13821335 |
| 57 | Ankle clonus (HP:0011448) | 2.11519070 |
| 58 | Entropion (HP:0000621) | 2.11508804 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.11421892 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10930826 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10930826 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10930826 |
| 63 | Anteriorly placed anus (HP:0001545) | 2.10634709 |
| 64 | Cellulitis (HP:0100658) | 2.04988550 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.03023145 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03023145 |
| 67 | Paralysis (HP:0003470) | 2.01919692 |
| 68 | Hyperthyroidism (HP:0000836) | 2.00125991 |
| 69 | Purpura (HP:0000979) | 1.99837820 |
| 70 | Microretrognathia (HP:0000308) | 1.96705949 |
| 71 | Urticaria (HP:0001025) | 1.96132253 |
| 72 | Myokymia (HP:0002411) | 1.96126335 |
| 73 | Hand muscle atrophy (HP:0009130) | 1.96004848 |
| 74 | Muscle fiber atrophy (HP:0100295) | 1.95826241 |
| 75 | Thrombocytosis (HP:0001894) | 1.95216685 |
| 76 | Myopathic facies (HP:0002058) | 1.93606045 |
| 77 | Malignant hyperthermia (HP:0002047) | 1.92126523 |
| 78 | Papilledema (HP:0001085) | 1.90754703 |
| 79 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90540242 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 1.88302373 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88302373 |
| 82 | Attenuation of retinal blood vessels (HP:0007843) | 1.87285202 |
| 83 | Upper limb amyotrophy (HP:0009129) | 1.86799093 |
| 84 | Distal upper limb amyotrophy (HP:0007149) | 1.86799093 |
| 85 | Combined immunodeficiency (HP:0005387) | 1.84985138 |
| 86 | Acute lymphatic leukemia (HP:0006721) | 1.81566294 |
| 87 | Gastrointestinal dysmotility (HP:0002579) | 1.81492732 |
| 88 | Atelectasis (HP:0100750) | 1.79138219 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.76440726 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 1.75983416 |
| 91 | Abnormality of macrophages (HP:0004311) | 1.75856368 |
| 92 | Encephalitis (HP:0002383) | 1.75646723 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 1.73582200 |
| 94 | Joint hemorrhage (HP:0005261) | 1.72891704 |
| 95 | Sepsis (HP:0100806) | 1.72608719 |
| 96 | Myotonia (HP:0002486) | 1.72536331 |
| 97 | Abnormality of the costochondral junction (HP:0000919) | 1.71768320 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 1.71599069 |
| 99 | Abnormality of T cells (HP:0002843) | 1.71391107 |
| 100 | Thin bony cortex (HP:0002753) | 1.70419826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.91902416 |
| 2 | TAOK2 | 3.59524704 |
| 3 | MAP3K11 | 3.58916845 |
| 4 | PRPF4B | 3.33730940 |
| 5 | TESK2 | 3.12103229 |
| 6 | TAOK3 | 2.83880833 |
| 7 | GRK6 | 2.32680791 |
| 8 | KIT | 2.31629602 |
| 9 | TXK | 2.27299096 |
| 10 | PIM2 | 2.18613693 |
| 11 | TBK1 | 2.11646443 |
| 12 | TAOK1 | 2.10778422 |
| 13 | PRKD3 | 2.05147363 |
| 14 | ARAF | 2.00560673 |
| 15 | ERN1 | 1.83205291 |
| 16 | PINK1 | 1.77481012 |
| 17 | MAP2K3 | 1.72416849 |
| 18 | BCKDK | 1.62455832 |
| 19 | FES | 1.61699255 |
| 20 | TESK1 | 1.59500762 |
| 21 | IKBKE | 1.57027694 |
| 22 | FLT3 | 1.55673359 |
| 23 | PRKD2 | 1.51928707 |
| 24 | DAPK2 | 1.50116984 |
| 25 | CAMKK2 | 1.41287651 |
| 26 | SIK2 | 1.39870430 |
| 27 | MAP3K12 | 1.36883124 |
| 28 | BLK | 1.32886876 |
| 29 | SCYL2 | 1.28438921 |
| 30 | SYK | 1.26008572 |
| 31 | IRAK4 | 1.23322497 |
| 32 | CAMKK1 | 1.19197881 |
| 33 | MARK2 | 1.18584153 |
| 34 | ZAP70 | 1.17829576 |
| 35 | MAP3K1 | 1.16291132 |
| 36 | MAPK11 | 1.16262070 |
| 37 | MAP3K3 | 1.05535357 |
| 38 | HCK | 1.05393613 |
| 39 | SIK3 | 1.05036065 |
| 40 | CSF1R | 1.04288175 |
| 41 | CCNB1 | 1.01490740 |
| 42 | DAPK1 | 0.99088351 |
| 43 | IRAK2 | 0.98031850 |
| 44 | NME2 | 0.97934240 |
| 45 | IKBKB | 0.96203024 |
| 46 | RIPK4 | 0.93793120 |
| 47 | TNK2 | 0.88397163 |
| 48 | MAP3K14 | 0.88079251 |
| 49 | MAP3K5 | 0.88036171 |
| 50 | MAPK15 | 0.83648968 |
| 51 | MAP3K13 | 0.79093953 |
| 52 | SIK1 | 0.78962854 |
| 53 | MAP3K7 | 0.78233912 |
| 54 | KDR | 0.77918216 |
| 55 | BTK | 0.77559965 |
| 56 | LCK | 0.76364081 |
| 57 | MAPK12 | 0.75591818 |
| 58 | VRK2 | 0.73952303 |
| 59 | RPS6KA2 | 0.73249574 |
| 60 | NME1 | 0.72918101 |
| 61 | TYK2 | 0.69959814 |
| 62 | MAP2K2 | 0.68254589 |
| 63 | ICK | 0.65295393 |
| 64 | TRIB3 | 0.63388667 |
| 65 | LYN | 0.63298538 |
| 66 | PDK1 | 0.60983858 |
| 67 | CSK | 0.59305406 |
| 68 | RPS6KC1 | 0.57856899 |
| 69 | RPS6KL1 | 0.57856899 |
| 70 | HIPK2 | 0.57565150 |
| 71 | DYRK1B | 0.55627667 |
| 72 | EPHB1 | 0.53718179 |
| 73 | CDC42BPA | 0.53258485 |
| 74 | PRKCQ | 0.53085353 |
| 75 | LIMK1 | 0.52745119 |
| 76 | RPS6KA6 | 0.51779604 |
| 77 | MATK | 0.51281986 |
| 78 | GRK7 | 0.50761846 |
| 79 | SMG1 | 0.47184152 |
| 80 | PRKD1 | 0.44789954 |
| 81 | MAP2K6 | 0.44629451 |
| 82 | DAPK3 | 0.43566460 |
| 83 | CSNK1G3 | 0.43561870 |
| 84 | NUAK1 | 0.42303523 |
| 85 | ABL2 | 0.41714535 |
| 86 | GRK5 | 0.41471497 |
| 87 | RAF1 | 0.39338724 |
| 88 | JAK3 | 0.38029479 |
| 89 | PDPK1 | 0.36453475 |
| 90 | PAK1 | 0.36157798 |
| 91 | PIM1 | 0.35261016 |
| 92 | JAK1 | 0.34424392 |
| 93 | RPS6KA5 | 0.32483434 |
| 94 | ITK | 0.32110145 |
| 95 | FYN | 0.31955115 |
| 96 | CAMK1 | 0.31203688 |
| 97 | PIK3CG | 0.29949962 |
| 98 | MAPK4 | 0.29903889 |
| 99 | PRKCD | 0.29668971 |
| 100 | PRKG2 | 0.29480754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 5.48451539 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.29051924 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.59819389 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34949368 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.18628270 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.15559312 |
| 7 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.14131426 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.13550378 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.12007161 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.87680321 |
| 11 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.81356365 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80986760 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77625995 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.73684835 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.62847886 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61065858 |
| 17 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.57939508 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52839100 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45949636 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.45736617 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43754229 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34770943 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.30529560 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.25677184 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.24840076 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22592107 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.21411920 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.19271392 |
| 29 | Endocytosis_Homo sapiens_hsa04144 | 1.16820602 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.15540945 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13663798 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10581144 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08335101 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01855725 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01687764 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01489689 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98888619 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.97687902 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.96280049 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96133271 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93882287 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93381818 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92502078 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91945437 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91727887 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.91099393 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89841774 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89356870 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86768602 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86151918 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 0.85365424 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.84283460 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.81970678 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81781061 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80590301 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 0.80225617 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79831871 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79668160 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78948877 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78264623 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77780085 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75938900 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70668094 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69965548 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.69716930 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68829495 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67739772 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66719327 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.65839491 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64859490 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63896447 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63456878 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62771819 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60763955 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60563879 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59338664 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59103799 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58222006 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.57650656 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56298096 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55815683 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55555882 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54227501 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52788180 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52552232 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52373139 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51709334 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51631924 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.49456673 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48541371 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.47792764 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45045128 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44484293 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44073063 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43349502 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42316051 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41487701 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.41344571 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40761629 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40756527 |

